A narrative “life” journey of a prescription drug molecule: From chemical synthesis to receptor binding in fish brain

Donelle J Duffin J Pipitone J White-Guay B . Assessing Canada’s drug shortage problem. CD Howe Institute Commentary 2018;515:1-27. Available: https://www.cdhowe.org/sites/default/files/attachments/research_papers/mixed/Commentary_515.pdf (accessed July 8, 2019).

Piachaud BS . Outsourcing in the pharmaceutical manufacturing process: an examination of the CRO experience. Technovation 2002;22(2):81-90.

Schweitzer S Lu J . The global pharmaceutical industry. In: Pharmaceutical Economics and Policy. 3rd ed. New York, NY: Oxford University Press; 2018:112-144.

World Health Organization. WHO good manufacturing practices: main principles for pharmaceutical products. In: Quality assurance of pharmaceuticals. 2nd ed. Geneva, Switzerland: World Health Organization; 2007:7-187.

Sundaram V Mathad VT Venkavala PJ , et al. Preparation of escitalopram (2009). US Patent No. 0018351 A1:1-17.

Pullareddy M Sambasiva Rao T Srinivasa Rao N . Process for the preparation of high-purity escitalopram (2005). World Intellectual Property Organization Patent No. 049596 A1:1-22.

World Health Organization. WHO good manufacturing practices: starting materials. In: Quality assurance of pharmaceuticals. 2nd ed. Geneva: World Health Organization; 2007:188-215.

Lee SL O’Connor TF Yang X , et al. Modernizing pharmaceutical manufacturing: from batch to continuous production. J Pharm Innov 2015;10(3):191-9.

Health Canada, Government of Canada. Drug Product Database Online Query. Available: https://health-products.canada.ca/dpd-bdpp/index-eng.jsp (accessed Dec. 9, 2017).

Health Canada. How to demonstrate foreign building compliance with drug good manufacturing practices (GUI-0080). 2018;1-36. Available: https://www.canada.ca/content/dam/hc-sc/documents/services/drug-health-product-review-approval/compliance-enforcement/good-manufacturing-practices/guidance-documents/gui-0080_final_en.pdf

Health Canada. Mutual recognition agreements. Available: https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/international/mutual-recognition-agreements.html (accessed Feb. 16, 2019).

Tousey MD . The Granulation Process 101: basic technologies for tablet making. Pharm Technol. 2002;26:8-13.

Competition Bureau of Canada. Canadian generic drug sector study. 2007. Available: https://www.ic.gc.ca/eic/site/cb-bc.nsf/eng/02495.html (accessed Jul. 8, 2019).

Rao N . The clinical pharmacokinetics of escitalopram. Clin Pharmacokinet 2007;46(4):281-90.

Toxicology Data Network (US National Libraries of Medicine). Escitalopram—environmental fate & exposure. Available: https://toxnet.nlm.nih.gov/cgi-bin/sis/search2/r?dbs+hsdb:@term+@rn+@rel+128196-01-0 (accessed Feb. 16, 2019).

Brooks BW Chambliss CK Stanley JK , et al. Determination of select antidepressants in fish from an effluent-dominated stream. Environ Toxicol Chem 2005;24(2):464-469.

Arnnok P Singh RR Burakham R Pérez-Fuentetaja A Aga DS . Selective uptake and bioaccumulation of antidepressants in fish from effluent-impacted Niagara River. Environ Sci Technol 2017;51(18):10652-62.